Increase the Spironolactone Dose
For a transgender woman with estradiol levels already in the 200 pg/mL range but persistently elevated testosterone, the next best option is to increase the spironolactone dose up to 200-300 mg daily. 1
Rationale Based on Guidelines
The 2017 AACE/Endocrine Society guidelines explicitly address this exact clinical scenario. When estradiol levels are adequate (100-200 pg/mL range, with your patient at 200 pg/mL) but testosterone remains elevated above the female physiologic range (<50 ng/dL), the guidelines specifically recommend increasing the antiandrogen dose rather than changing estrogen formulations or increasing estrogen doses 1.
The case discussion in the guidelines presents a patient with estradiol of 96 pg/mL and testosterone of 120 ng/dL, where both estrogen AND spironolactone doses were increased. In your scenario, with estradiol already at 200 pg/mL (at the upper end of the target range), increasing estrogen further would risk supraphysiologic levels and associated complications including thromboembolism 2.
Specific Dosing Algorithm
- Current standard spironolactone dosing: 100-300 mg daily 1
- If the patient is on less than 200 mg daily, titrate upward in 50-100 mg increments
- Monitor electrolytes given spironolactone's potassium-sparing effects
- Reassess hormone levels in 3 months during the first year of therapy 1
Alternative Antiandrogen Options
If spironolactone at maximum doses (200-300 mg daily) fails to adequately suppress testosterone, consider:
GnRH Agonists
GnRH agonists (such as goserelin acetate) are highly effective for testosterone suppression with low adverse event rates 2. The Endocrine Society guidelines note that GnRH agonists effectively reduce testosterone levels to the female range when combined with estrogen 2. However, cost is typically prohibitive compared to spironolactone 1.
Cyproterone Acetate
Cyproterone acetate (widely used in Europe) is another progestational antiandrogen option 2. Recent evidence suggests low-dose cyproterone (10-20 mg daily) is as effective as high-dose (50-100 mg daily) for testosterone suppression, with potentially better safety profiles 3. However, this medication is not FDA-approved in the United States.
What NOT to Do
Do not add finasteride - The guidelines explicitly state that finasteride will not lower testosterone values and can be associated with increased mood disturbances 1. Finasteride only blocks conversion of testosterone to dihydrotestosterone; it does not suppress testosterone production.
Do not switch estrogen formulations - With estradiol already at 200 pg/mL, changing formulations is unnecessary and won't address the testosterone elevation 1.
Common Pitfalls
Relying solely on estrogen for testosterone suppression: While high-dose estrogen monotherapy can suppress testosterone, this approach risks supraphysiologic estradiol levels and increased thromboembolism risk 2, 4. Research shows that oral estradiol alone frequently fails to achieve adequate testosterone suppression 4.
Inadequate spironolactone dosing: Many patients are started on 50-100 mg daily, but the guidelines support doses up to 300 mg daily 1.
Not monitoring electrolytes: Spironolactone can cause hyperkalemia, particularly at higher doses.
Monitoring Parameters
Recheck hormone levels in 3 months: